Osteoporosis

Risedronate Sodium Reduces Clinical Vertebral Fractures

Published in Women's Health Weekly, November 15th, 2001

New findings from clinical studies in 2442 postmenopausal women offer evidence that Actonel (risedronate sodium tablets) 5 mg reduced clinical vertebral (spinal) fractures as early as 6 months (p<0.01).

Clinical vertebral fractures were reported as adverse events and all were confirmed radiographically. The data were presented in October (2001) at the American Society for Bone and Mineral Research (ASBMR) 23rd Annual Meeting in Phoenix, Arizona.

"It is important that we intervene as early as possible in patients at risk for fracture, and initiate fast and effective treatment, like Actonel, to stop the fracture cascade that often occurs,"...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Women's Health Weekly

Source: Women's Health Weekly (2001-11-15)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry